IL99429A0 - Peptide inhibitors of lymphocyte response and immune-related diseases - Google Patents

Peptide inhibitors of lymphocyte response and immune-related diseases

Info

Publication number
IL99429A0
IL99429A0 IL99429A IL9942991A IL99429A0 IL 99429 A0 IL99429 A0 IL 99429A0 IL 99429 A IL99429 A IL 99429A IL 9942991 A IL9942991 A IL 9942991A IL 99429 A0 IL99429 A0 IL 99429A0
Authority
IL
Israel
Prior art keywords
immune
related diseases
peptide inhibitors
lymphocyte response
lymphocyte
Prior art date
Application number
IL99429A
Other languages
English (en)
Original Assignee
Univ Utrecht
Yeda Res & Dev
Nat Inst Of Public Health And
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utrecht, Yeda Res & Dev, Nat Inst Of Public Health And filed Critical Univ Utrecht
Publication of IL99429A0 publication Critical patent/IL99429A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL99429A 1990-09-06 1991-09-06 Peptide inhibitors of lymphocyte response and immune-related diseases IL99429A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57850690A 1990-09-06 1990-09-06

Publications (1)

Publication Number Publication Date
IL99429A0 true IL99429A0 (en) 1992-08-18

Family

ID=24313172

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99429A IL99429A0 (en) 1990-09-06 1991-09-06 Peptide inhibitors of lymphocyte response and immune-related diseases

Country Status (8)

Country Link
EP (1) EP0503055A1 (cg-RX-API-DMAC7.html)
JP (1) JPH05507501A (cg-RX-API-DMAC7.html)
AU (1) AU650065B2 (cg-RX-API-DMAC7.html)
CA (1) CA2071896A1 (cg-RX-API-DMAC7.html)
IL (1) IL99429A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ239699A (cg-RX-API-DMAC7.html)
WO (1) WO1992004049A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA917097B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09509135A (ja) * 1993-06-02 1997-09-16 ティーヴィダブリュー テレソン インスティテュート フォー チャイルド ヘルス リサーチ 免疫寛容の誘導における利用のためのクリプティックペプチド
ES2216009T3 (es) * 1994-03-21 2004-10-16 Rijksuniversiteit Utrecht Fragmentos peptidicos de proteinas de estres microbianas y composicion farmaceutica a base de estos para el tratamiento y la prevencion de enfermedades inflamatorias.
GB9419553D0 (en) * 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
IT1271074B (it) * 1994-11-21 1997-05-26 Italfarmaco Spa Peptidi ad attivita' antiinfiammatoria
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
EP0994717A4 (en) * 1997-01-24 2000-07-26 Autoimmune Inc TREATING AUTOIMMUNE DISEASES BY TOLERANCE INCREASED BY COMBINING WITH METHOTREXATE
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
EP2157101B1 (en) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP peptides and analogs for modulation of immune responses via antigen presenting cells
EP1575526B1 (en) 2002-05-21 2012-06-06 Irun R. Cohen Dna vaccines encoding heat shock proteins
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation

Also Published As

Publication number Publication date
CA2071896A1 (en) 1992-03-07
EP0503055A4 (cg-RX-API-DMAC7.html) 1994-02-16
JPH05507501A (ja) 1993-10-28
AU650065B2 (en) 1994-06-09
WO1992004049A1 (en) 1992-03-19
EP0503055A1 (en) 1992-09-16
ZA917097B (en) 1992-09-30
AU8755991A (en) 1992-03-30
NZ239699A (en) 1993-11-25

Similar Documents

Publication Publication Date Title
KR970009081B1 (en) Vectors and compounds for direct expression of activated human protein c
EP0785276A4 (en) MODIFICATION OF A PEPTIDE AND A PROTEIN
IL108079A0 (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
ZA967654B (en) Electrodes and methods of preparation thereof
IL99429A0 (en) Peptide inhibitors of lymphocyte response and immune-related diseases
IL115015A0 (en) Methods of inhibiting demyelinating and desmyelinating diseases
KR890700602A (ko) 면역억제성 펩타이드 및 사용방법
EP0443875A3 (en) Vectors and compounds for expression of zymogen forms of human protein c
HU893412D0 (en) Inhibitors of interleucin-1
EP0450598A3 (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
CS135591A2 (en) Method of peptide preparation
JPS6450900A (en) Carboxamide derivative of glycopeptide
DE3268774D1 (en) Isolation of protein and peptide from urine
IL92506A0 (en) Detection of inflammatory diseases
GB2280439B (en) CD4 binding agents and inhibitors of collagenase and protein kinase C
GB8923571D0 (en) Connecting means and method of use thereof
AU1719988A (en) Aminopeptidase for removing n-terminal methionine from proteins and proteins prepared therefrom
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
EP0450813A3 (en) Protein phosphatase inhibitor-1 gene and expression
GB9405905D0 (en) Inhibitors of isoprenylated protein endoprotease
EP0354819A3 (en) Novel peptide and anti-dementia agent
AU4527389A (en) Amino acid and peptide inhibitors of human leukocytic elastase and collagenase
GB8802858D0 (en) Detection of protein
JPS6490196A (en) Inhibitor peptide i and ii
AU8939691A (en) Peptide inhibitors of neutrophil activation proteins